Genomics and Precision Health

Improving health through the development of targeted treatments based on genetics.

About us

We aim to translate knowledge from genomics research to improve human health, by discovering better methods of diagnosing disease, developing targeted treatments based on genetics, and training the next generation of translational genomics scientists.

Our research spans the design, development, and application of methods for genomic discovery, analysis and translation to advance genomics-driven healthcare and drive outcomes in the real world of clinical and personalised health.

Our research focuses on:

  • genomic epidemiology and analysis
  • diagnostics and functional genomics
  • genomic instability and disease
  • translational and pharmacogenomics
  • personalised therapies

Research projects

Genomics and spatial profiling in liver disease

Lead Researcher: Professor Nathan Subramaniam

Liver disease encompasses many conditions that affect the liver and its function. These range from liver fibrosis, the common non-alcoholic fatty liver disease (NAFLD), the more severe non-alcoholic steatohepatitis (NASH), all the way to liver cirrhosis and hepatocellular carcinoma.

Some patients progress very rapidly through the various stages of liver disease to liver cirrhosis while others are more protected. Understanding the genetics and genomics of this disease and the molecular changes that are associated with the development and progression of liver disease is the key to understanding mechanisms, developing diagnostics, and designing effective therapies.

This project will utilise state-of-the-art technology to examine the molecular and cellular changes that the liver undergoes during liver disease progression to identify novel biomarkers for early detection and targets for effective therapies. It will result in substantial advances to our knowledge of liver disease and lead to the development of new biomarkers and eventually better personalised therapies for patients.

Learn more

Modulating fibrosis with natural compounds

Lead Researcher: Professor Nathan Subramaniam

Small molecule libraries have been previously used to try and identify anti-fibrotic molecules, but these studies used indirect readouts to measure the effectiveness of the compounds. We have a unique cell line expressing green fluorescent protein (GFP) which can be effectively used to identify external/internal changes in the cells. This project will utilise these cells and natural compound libraries from Compounds Australia to identify molecules that can either increase or decrease collagen expression.

The overall aims of this study are to identify and characterise naturally occurring compounds that can modulate the expression of collagen. This project will utilise the high-throughput imaging facilities at QUT to image collagen and other morphological features of the cell after treatment with the screening compounds. Hepatic cell lines will be utilised to examine the molecular pathways through which the targets identified.

Expected outcomes will be the identification of small molecules that can be used to treat liver disease which will then proceed to pre-clinical studies and if successful, followed by clinical studies.

Learn more

Identification and functional characterisation of genetic modifiers of iron overload

Lead Researcher: Professor Nathan Subramaniam

Iron is an element essential for virtually all life forms; aberrant iron metabolism is linked to many diseases. These include cancers, neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, iron overload and iron deficiency disorders, iron-loading anaemias, and the anaemia associated with chronic disease.

Central to proper iron regulation is the appropriate expression and activity of the liver-expressed regulatory peptide, hepcidin, and the iron exporter, ferroportin (FPN). Modulating the expression and activity of hepcidin and FPN, and their interaction is thus a focus of many therapeutic interventions.

We have identified a new mechanism by which ferroportin is regulated. This finding was made possible through the systematic analysis of a cohort of Australian patients with iron overload. Our research proposal builds on this exciting new finding.

This project will analyse the mechanistic role of these novel proteins in iron homeostasis and FPN regulation, investigate the role of these novel proteins in iron homeostasis in animal models of dysregulated iron homeostasis, and determine the functional consequences of mutations in these novel proteins and prevalence in subjects with iron overload.

Investigating DNA repair mechanisms in aging adult stem cells

Lead Researcher: Professor Derek Richard

When we age the DNA repair systems of our cells become down regulated. This results in reduced DNA repair capacity, enhanced rates of mutation load and may lead to the development of chronic aging-associated diseases including osteoporosis, Alzheimer's and cancer. So it is no surprise that genome instability and stem cell exhaustion, which also strongly correlates with the accumulation of DNA damage, are considered hallmarks of aging.

However, we still lack a clear understanding on how the decrease in DNA repair fidelity affects adult stem cells and their ability to contribute to tissue maintenance and regeneration. We also lack a comprehensive understanding of which specific pathways and proteins are involved in the DNA repair of skeletal stem cells and how the decline of repair processes with age contributes to musculoskeletal diseases such as osteoporosis and osteoarthritis.

This project will characterise the DNA damage responses in young and aged skeletal progenitor cells and how the DNA repair mechanism are affected by cell cycle exit and differentiation.

Learn more

The role of genetics in post-traumatic headaches

Lead Researcher: Professor Lyn Griffiths

Traumatic brain injury symptoms can vary significantly and can include a range of neurological dysfunctions, including migraine and persistent headache, but also cognitive deficit, confusion, slowed reaction times, personality changes, drowsiness and emotional changes.

While most people have acute and relatively short-lived effects, in some cases symptoms are known to persist for weeks or months, and sometimes years, which results in a diagnosis of post-concussion syndrome. Post-concussion syndrome as a whole is not well understood, and we don’t know why some people suffer prolonged symptoms such as severe and persistent headaches and others don’t.

We think that genetic variation may play a role, so this project is looking at a range of genes focusing in particular on those involved in nerve function.

Learn more

Maternal diet and infant microbiome

Connect with us

QUT Faculty of Health | FacebookQUT Faculty of Health | TwitterQUT Faculty of Health | LinkedIn

Future students

3138 2000 (Australian and NZ)

07 3138 9944 (International)

Industry and alumni